7,906 Shares in Waters Corporation $WAT Acquired by Figure 8 Investment Strategies LLC

Posted by Francis Steltz on Aug 19th, 2026

Figure 8 Investment Strategies LLC acquired a new stake in shares of Waters Corporation (NYSE:WAT – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 7,906 shares of the medical instruments supplier’s stock, valued at approximately $2,965,000. Waters comprises approximately 2.5% of Figure 8 Investment Strategies LLC’s investment portfolio, making the stock its 13th largest holding.

Other institutional investors have also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT increased its stake in shares of Waters by 121.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 40 shares during the last quarter. SHP Wealth Management bought a new position in shares of Waters during the 4th quarter valued at $32,000. DV Equities LLC acquired a new stake in shares of Waters in the 4th quarter valued at $32,000. Anchor Investment Management LLC acquired a new stake in shares of Waters in the 1st quarter valued at $27,000. Finally, Resources Management Corp CT ADV bought a new stake in Waters in the first quarter worth $27,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Waters

In related news, Director Christopher A. Kuebler sold 3,626 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the sale, the director owned 17,808 shares in the company, valued at $7,086,515.52. This represents a 16.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.31% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on WAT. Robert W. Baird set a $387.00 target price on shares of Waters in a research report on Wednesday, May 6th. Wells Fargo & Company upped their price target on Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 5th. Royal Bank Of Canada increased their price objective on Waters from $435.00 to $475.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Citigroup raised their price objective on Waters from $425.00 to $470.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $400.00 target price on shares of Waters in a report on Wednesday, August 5th. Three investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $420.35.

Get Our Latest Stock Report on Waters

Waters Stock Performance

Shares of WAT opened at $401.78 on Wednesday. The company has a market capitalization of $39.47 billion, a PE ratio of 100.19, a price-to-earnings-growth ratio of 2.40 and a beta of 1.19. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.86 and a quick ratio of 1.29. Waters Corporation has a one year low of $282.77 and a one year high of $420.26. The company’s fifty day moving average price is $378.68 and its 200 day moving average price is $346.24.

Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.01 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The business’s quarterly revenue was up 113.3% compared to the same quarter last year. During the same period in the prior year, the company earned $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. As a group, analysts expect that Waters Corporation will post 14.57 earnings per share for the current year.

Waters Company Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.